Literature DB >> 16564576

Transforming growth factor beta 1(TGF-beta1) down-regulates TNFalpha-induced RANTES production in rheumatoid synovial fibroblasts through NF-kappaB-mediated transcriptional repression.

Mi-La Cho1, So-Youn Min, Soog-Hee Chang, Kyoung-Woon Kim, Seong-Bum Heo, Sang-Heon Lee, Sung-Hwan Park, Chul-Soo Cho, Ho-Youn Kim.   

Abstract

Transforming growth factor (TGF)-beta1 is a pleiotropic cytokine with many functions, including those related to growth modulation, immunosuppression, and pro-inflammation, in a wide variety of cell types. In this study, we investigated the ability of TGF-beta1 to regulate RANTES production by activated rheumatoid synovial fibroblasts. Fibroblast-like synoviocytes (FLS) were cultured in the presence of TGF-beta1 and IL-1beta, IL-15, TNFalpha, or IL-17, and the secretion of RANTES into culture supernatants was measured by enzyme-linked immunosorbent assay (ELISA). Expression of RANTES encoded mRNA was determined by reverse transcription-polymerase chain reaction (RT-PCR), and NF-kappaB binding activity for RANTES transcription was determined by electrophoretic mobility shift assay (EMSA). We found that the concentrations of RANTES in synovial fluid (SF) from rheumatoid arthritis (RA) patients were lower than in SF from osteoarthritis (OA) patients, whereas the concentrations of TGF-beta1 were higher in RA SF than in OA SF. TGF-beta1 dose-dependently inhibited TNFalpha-induced production of RANTES protein and mRNA from RA FLS. Addition of RA SF with high-level TGF-beta1 mimicked the effect of TGF-beta1 on TNFalpha-induced RANTES production, which was inhibited by treatment with anti-TGF-beta1 neutralizing antibody. TGF-beta1 blocked the degradation of cytosolic IkappaB-alpha and the translocation of activated NF-kappaB to the nucleus. EMSA showed that the inhibitory effect of TGF-beta1 was associated with decreased binding of NF-kappaB to the RANTES promoter. These results suggest that elevated TGF-beta1 in rheumatoid synovial tissue may suppress joint inflammation by inhibiting RANTES secretion from synovial fibroblasts, thus blocking the infiltration of immune cells. These findings may provide an explanation for the mechanism by which TGF-beta1 regulates immune function in RA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16564576     DOI: 10.1016/j.imlet.2006.02.003

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  15 in total

1.  Inhibition of proinflammatory RANTES expression by TGF-beta1 is mediated by glycogen synthase kinase-3beta-dependent beta-catenin signaling.

Authors:  Chunsun Dai; Xiaoyan Wen; Weichun He; Youhua Liu
Journal:  J Biol Chem       Date:  2010-12-28       Impact factor: 5.157

2.  Oral administration of transforming growth factor-β1 (TGF-β1) protects the immature gut from injury via Smad protein-dependent suppression of epithelial nuclear factor κB (NF-κB) signaling and proinflammatory cytokine production.

Authors:  Sheng-Ru Shiou; Yueyue Yu; Yuee Guo; Maria Westerhoff; Lei Lu; Elaine O Petrof; Jun Sun; Erika C Claud
Journal:  J Biol Chem       Date:  2013-10-15       Impact factor: 5.157

3.  Astrocytic TGF-β signaling limits inflammation and reduces neuronal damage during central nervous system Toxoplasma infection.

Authors:  Egle Cekanaviciute; Hans K Dietrich; Robert C Axtell; Aaron M Williams; Riann Egusquiza; Karen M Wai; Anita A Koshy; Marion S Buckwalter
Journal:  J Immunol       Date:  2014-05-23       Impact factor: 5.422

4.  Thrombocytopenia May Mediate Disease Severity in Plasmodium falciparum Malaria Through Reduced Transforming Growth Factor Beta-1 Regulation of Proinflammatory and Anti-inflammatory Cytokines.

Authors:  Benjamin R Hanisch; Paul Bangirana; Robert O Opoka; Gregory S Park; Chandy C John
Journal:  Pediatr Infect Dis J       Date:  2015-07       Impact factor: 2.129

Review 5.  Regulation and Role of TGFβ Signaling Pathway in Aging and Osteoarthritis Joints.

Authors:  Catherine Baugé; Nicolas Girard; Eva Lhuissier; Celine Bazille; Karim Boumediene
Journal:  Aging Dis       Date:  2013-12-17       Impact factor: 6.745

6.  Platelet-derived growth factor and transforming growth factor beta synergistically potentiate inflammatory mediator synthesis by fibroblast-like synoviocytes.

Authors:  Sanna Rosengren; Maripat Corr; David L Boyle
Journal:  Arthritis Res Ther       Date:  2010-04-09       Impact factor: 5.156

7.  Oncostatin M regulates secretoglobin 3A1 and 3A2 expression in a bidirectional manner.

Authors:  Takeshi Tomita; Atsushi Yamada; Masaaki Miyakoshi; Taketomo Kido; Faruk Sheikh; Achara Srisodsai; Atsushi Miyajima; Raymond P Donnelly; Shioko Kimura
Journal:  Am J Respir Cell Mol Biol       Date:  2008-10-31       Impact factor: 6.914

8.  Constitutive upregulation of the transforming growth factor-beta pathway in rheumatoid arthritis synovial fibroblasts.

Authors:  Dirk Pohlers; Andreas Beyer; Dirk Koczan; Thomas Wilhelm; Hans-Jürgen Thiesen; Raimund W Kinne
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

9.  Cells of the synovium in rheumatoid arthritis. Synovial fibroblasts.

Authors:  Ulf Müller-Ladner; Caroline Ospelt; Steffen Gay; Oliver Distler; Thomas Pap
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

10.  Regulation of chemokine CCL5 synthesis in human peritoneal fibroblasts: a key role of IFN-γ.

Authors:  Edyta Kawka; Janusz Witowski; Nina Fouqet; Hironori Tayama; Thorsten O Bender; Rusan Catar; Duska Dragun; Achim Jörres
Journal:  Mediators Inflamm       Date:  2014-01-09       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.